Diastolic pulmonary vascular pressure gradient: A predictor of prognosis in "out-of-proportion" pulmonary hypertension

Chest

Volumn 143, Issue 3, 2013, Pages 758-766

  Gerges, Christian ^a   Gerges, Mario ^a   Lang, Marie B ^a   Zhang, Yuhui ^a   Jakowitsch, Johannes ^a   Probst, Peter ^a   Maurer, Gerald ^a   Lang, Irene M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; CONTROLLED STUDY; DEATH; DIAGNOSTIC VALUE; DIASTOLIC PULMONARY VASCULAR PRESSURE GRADIENT; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEFT SIDED HEART DISEASE; LUNG BLOOD VESSEL; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESSURE GRADIENT; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; REVIEW; SURVIVAL;

EID: 84874970007     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1653     Document Type: Article

References (33)

1. West JB, Mathieu-Costello O. Vulnerability of pulmonary capillaries in heart disease. Circulation. 1995; 92 (3): 622-631.
2. Kerem A, Yin J, Kaestle SM, et al. Lung endothelial dysfunction in congestive heart failure: role of impaired Ca2 1 signaling and cytoskeletal reorganization. Circ Res. 2010; 106 (6): 1103-1116.
3. Galiè N, Hoeper MM, Humbert M, et al ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009; 30 (20): 2493-2537.
4. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006; 25(9):1024-1042.
5. Buchbinder N, Ganz W. Hemodynamic monitoring: invasive techniques. Anesthesiology. 1976; 45 (2): 146-155.
6. Stevens PM. Assessment of acute respiratory failure: cardiac versus pulmonary causes. Chest. 1975; 67 (1): 1-2.
7. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001; 37 (1): 183-188.
8. Lam CS, Borlaug BA, Kane GC, Enders FT, Rodeheffer RJ, Redfield MM. Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation. 2009; 119 (20): 2663-2670.
9. Aronson D, Eitan A, Dragu R, et al. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure. Circulation. Heart Fail. 2011; 4 (5): 644-650.
10. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009; 53 (13): 1119-1126.
11. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest. 2007; 132 (3): 998-1006.
12. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005; 127 (5): 1531-1536.
13. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003; 62 (11): 1088-1093.
14. Lang I, Gomez-Sanchez M, Kneussl M, et al. Efficacy of longterm subcutaneous treprostinil sodium therapy in pulmonary hypertension. Chest. 2006; 129 (6): 1636-1643.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16 (1): 31-41.
16. Bonderman D, Jakowitsch J, Redwan B, et al. Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2008; 28 (4): 678-684.
17. Du L, Sullivan CC, Chu D, et al. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med. 2003; 348 (6): 500-509.
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44 (3): 837-845.
19. Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed. 1997; 54 (3): 201-208.
20. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996; 17 (4): 343-346.
21. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009; 54 (suppl 1): S43 - S54.
22. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355 (3): 251-259.
23. Damy T, Goode KM, Kallvikbacka-Bennett A, et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J. 2010; 31 (18): 2280-2290.
24. Manzano L, Babalis D, Roughton M, et al SENIORS Investigators. Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail. 2011; 13 (5): 528-536.
25. Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997; 29 (1): 153-159.
26. Rich S, Rabinovitch M. Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. Circulation. 2008; 118 (21): 2190-2199.
27. Kapanci Y, Burgan S, Pietra GG, Conne B, Gabbiani G. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am J Pathol. 1990; 136 (4): 881-889.
28. Tandon HD, Kasturi J. Pulmonary vascular changes associated with isolated mitral stenosis in India. Br Heart J. 1975; 37 (1): 26-36.
29. Capomolla S, Febo O, Guazzotti G, et al. Invasive and noninvasive determinants of pulmonary hypertension in patients with chronic heart failure. J Heart Lung Transplant. 2000; 19(5):426-438.
30. Tedford RJ, Hassoun PM, Mathai SC, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation. 2012; 125 (2): 289-297.
31. Chemla D, Castelain V, Herve P, et al. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J. 2002 ;20(5): 1314-1331.
32. Harvey RM, Enson Y, Ferrer MI. A reconsideration of the origins of pulmonary hypertension. Chest. 1971; 59 (1): 82-94.
33. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS; Evidence-Based Medicine Working Group. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA. 2000; 284 (1): 79-84.